{"recall":{"id":"fda-drug-99990","source":"FDA","sourceName":"U.S. Food and Drug Administration (openFDA drug enforcement)","cat":"medicines","kids":false,"kind":"drug","title":"Houston Rx LLC recalls 2 products","firm":"Houston Rx LLC","date":"2026-09-25","reported":"2026-10-21","status":"Ongoing","classification":"Class II","products":[{"name":"Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.","code":"Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.","quantity":"64 vials","number":"D-0040-2027","classification":"Class II"},{"name":"Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.","code":"Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026.","quantity":"7 vials","number":"D-0041-2027","classification":"Class II"}],"reason":"Lack of assurance of sterility. Lack of process control","hazard":"FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).","affected":"Nationwide in the USA.","nationwide":true,"states":[],"units":"64 vials; 7 vials","remedy":"","whatToDo":"Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.","contact":"","url":"https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99990","apiUrl":"https://api.fda.gov/drug/enforcement.json?search=report_date:[20260705+TO+20991231]&sort=report_date:desc&limit=1000","rawHash":"d909186883e0e305","firstSeen":"2026-11-02T13:57:14.206Z","updatedAt":"2026-11-02T13:57:14.206Z","history":[]},"official":{"fetchedAt":"2026-11-02T13:57:14.206Z","apiUrl":"https://api.fda.gov/drug/enforcement.json?search=report_date:[20260705+TO+20991231]&sort=report_date:desc&limit=1000","officialUrl":"https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99990","record":[{"status":"Ongoing","city":"Houston","state":"TX","country":"United States","classification":"Class II","openfda":{},"product_type":"Drugs","event_id":"99990","recalling_firm":"Houston Rx LLC","address_1":"15340 Vantage Pkwy E Ste 220","address_2":"","postal_code":"77032-1901","voluntary_mandated":"Voluntary: Firm initiated","initial_firm_notification":"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit","distribution_pattern":"Nationwide in the USA.","recall_number":"D-0040-2027","product_description":"Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.","product_quantity":"64 vials","reason_for_recall":"Lack of assurance of sterility.","recall_initiation_date":"20260925","center_classification_date":"20261013","report_date":"20261021","code_info":"Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.","more_code_info":""},{"status":"Ongoing","city":"Houston","state":"TX","country":"United States","classification":"Class II","openfda":{},"product_type":"Drugs","event_id":"99990","recalling_firm":"Houston Rx LLC","address_1":"15340 Vantage Pkwy E Ste 220","address_2":"","postal_code":"77032-1901","voluntary_mandated":"Voluntary: Firm initiated","initial_firm_notification":"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit","distribution_pattern":"Nationwide in the USA.","recall_number":"D-0041-2027","product_description":"Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.","product_quantity":"7 vials","reason_for_recall":"Lack of process control","recall_initiation_date":"20260925","center_classification_date":"20261013","report_date":"20261021","code_info":"Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026.","more_code_info":""}]}}